Flagship Ventures Fund IV General Partner LLC's most recent trades

10% Owner

%

COMPANY

SHARES

NET TOTAL

62.99%

SERES THERAPEUTICS INC

12,682,876

$368,438,000.00

20.67%

EDITAS MEDICINE INC

4,955,316

$120,910,000.00

14.92%

SYROS PHARMACEUTICALS INC

4,806,656

$87,241,000.00

1.00%

T2 BIOSYSTEMS INC

741,755

$5,852,000.00

0.42%

ELEVEN BIOTHERAPEUTICS INC

1,466,417

$2,464,000.00